Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2006 1
2012 2
2013 11
2014 30
2015 32
2016 36
2017 18
2018 23
2019 22
2020 26
2021 35
2022 26
2023 11
2024 21
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean julia (11,128 results)?
Onychomycosis: a review.
Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, Piraccini BM. Gupta AK, et al. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1972-1990. doi: 10.1111/jdv.16394. Epub 2020 Jun 5. J Eur Acad Dermatol Venereol. 2020. PMID: 32239567 Review.
Terbinafine, itraconazole and fluconazole are most commonly used, with new oral antifungals such as fosravuconazole being evaluated. Topical treatments, such as efinaconazole, tavaborole, ciclopirox and amorolfine have less serious side effects, but also have generally low …
Terbinafine, itraconazole and fluconazole are most commonly used, with new oral antifungals such as fosravuconazole being evaluated. Topical …
Triazole antifungals: a review.
Peyton LR, Gallagher S, Hashemzadeh M. Peyton LR, et al. Drugs Today (Barc). 2015 Dec;51(12):705-18. doi: 10.1358/dot.2015.51.12.2421058. Drugs Today (Barc). 2015. PMID: 26798851 Review.
Second-generation triazoles such as voriconazole, posa-conazole, albaconazole, efinaconazole, ravuconazole and isavuconazole are all derivatives of either itraconazole or fluconazole, and designed to overcome the deficiencies of their parent drugs. ...
Second-generation triazoles such as voriconazole, posa-conazole, albaconazole, efinaconazole, ravuconazole and isavuconazole are all …
Onychomycosis: Rapid Evidence Review.
Frazier WT, Santiago-Delgado ZM, Stupka KC 2nd. Frazier WT, et al. Am Fam Physician. 2021 Oct 1;104(4):359-367. Am Fam Physician. 2021. PMID: 34652111 Free article. Review.
Topical therapy, including ciclopirox 8%, efinaconazole 10%, and tavaborole 5%, is less effective than oral agents but can be used to treat mild to moderate onychomycosis, with fewer adverse effects and drug-drug interactions. ...
Topical therapy, including ciclopirox 8%, efinaconazole 10%, and tavaborole 5%, is less effective than oral agents but can be used to …
Pharmacoeconomic Review Report: Efinaconazole (Jublia): (Valeant Canada LP): Indication: For the topical treatment of mild-to-moderate onychomycosis (tinea unguium) of toenails without lunula involvement due to Trichophyton rubrum and Trichophyton mentagrophytes in immunocompetent adult patients.
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun. PMID: 31287636 Free Books & Documents. Review.
Efinaconazole topical solution 10% w/w (Jublia) is a triazole antifungal agent indicated for the topical treatment of mild-to-moderate onychomycosis (tinea unguium) of toenails without lunula involvement due to Trichophyton rubrum and T. mentagrohytes in immunocompe …
Efinaconazole topical solution 10% w/w (Jublia) is a triazole antifungal agent indicated for the topical treatment of mild-to- …
JUBLIA (Efinaconazole 10% Solution) in the Treatment of Pediatric Onychomycosis.
Gupta AK, Venkataraman M, Abramovits W, Guenin EP. Gupta AK, et al. Skinmed. 2021 Jun 1;19(3):206-210. eCollection 2021. Skinmed. 2021. PMID: 34303391
In general, these oral agents have been found to be safe and effective for pediatric onychomycosis. The available topical agents are efinaconazole solution 10%, tavaborole solution 5%, and ciclopirox nail lacquer topical solution 8%. ...Treatment was for 48 weeks, with fol …
In general, these oral agents have been found to be safe and effective for pediatric onychomycosis. The available topical agents are efin …
Clinical Review Report: Efinaconazole (Jublia): (Valeant Canada LP): Indication: For the topical treatment of mild-to-moderate onychomycosis (tinea unguium) of toenails without lunula involvement due to Trichophyton rubrum and Trichophyton mentagrophytes in immunocompetent adult patients.
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun. PMID: 31305972 Free Books & Documents. Review.
The objective of this review is to perform a systematic review of the beneficial and harmful effects of efinaconazole for the topical treatment of mild-to-moderate onychomycosis (tinea unguium) of toenails without lunula involvement due to Trichophyton rubrum and Trichophy …
The objective of this review is to perform a systematic review of the beneficial and harmful effects of efinaconazole for the topical …
Efinaconazole.
[No authors listed] [No authors listed] 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999786 Free Books & Documents. Review.
Topical efinaconazole has not been studied during breastfeeding. Because maternal blood levels are very low after topical application to the toenails, it is unlikely that a measurable amount of the drug will enter the breastmilk....
Topical efinaconazole has not been studied during breastfeeding. Because maternal blood levels are very low after topical application …
Updated Perspectives on the Diagnosis and Management of Onychomycosis.
Falotico JM, Lipner SR. Falotico JM, et al. Clin Cosmet Investig Dermatol. 2022 Sep 15;15:1933-1957. doi: 10.2147/CCID.S362635. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36133401 Free PMC article. Review.
Oral terbinafine, itraconazole, and griseofulvin and topical ciclopirox 8% nail lacquer, efinaconazole 10% solution, and tavaborole 5% solution are approved by the Food and Drug Administration for treatment of onychomycosis in the United States and amorolfine 5% nail lacqu …
Oral terbinafine, itraconazole, and griseofulvin and topical ciclopirox 8% nail lacquer, efinaconazole 10% solution, and tavaborole 5 …
Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics.
Yousefian F, Smythe C, Han H, Elewski BE, Nestor M. Yousefian F, et al. J Clin Aesthet Dermatol. 2024 Mar;17(3):24-33. J Clin Aesthet Dermatol. 2024. PMID: 38495549 Free PMC article. Review.
METHODS: A literature search was conducted using electronic databases (PubMed, Embase, Medline, CINAHL, EBSCO) and textbooks, in addition to the clinical experiences of the authors and other practitioners in treating onychomycosis, and a summary of the findings are presented here …
METHODS: A literature search was conducted using electronic databases (PubMed, Embase, Medline, CINAHL, EBSCO) and textbooks, in addition to …
272 results